Loading...
XKRX006490
Market cap124mUSD
Dec 26, Last price  
1,414.00KRW
1D
-2.85%
1Q
37.77%
Jan 2017
-10.15%
Name

Inscobee Inc

Chart & Performance

D1W1MN
XKRX:006490 chart
P/E
—
P/S
1.68
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
5.02%
Rev. gr., 5y
11.24%
Revenues
99.81b
+30.17%
20,982,949,0005,290,198,0005,333,726,0005,086,295,0005,475,542,8607,984,670,83012,341,843,49025,770,467,65016,313,400,46037,062,381,44049,566,496,85058,590,555,34075,277,435,09057,817,812,93071,665,525,21076,678,321,79099,811,312,707
Net income
-30.18b
L+307.35%
2,272,424,000202,051,000-8,984,956,000-34,281,088,000-3,529,425,020-8,718,764,000-7,114,930,000-7,957,420,000-23,503,008,000-6,115,956,000-511,438,000-8,325,400,670-24,905,320,0109,306,361,4205,304,170,150-7,408,062,510-30,176,927,150
CFO
3.01b
P
-4,732,129,000-8,417,861,000-20,595,675,000-7,605,257,860-3,702,963,440-6,376,013,710-8,268,462,790-5,487,498,320-285,501,1501,475,493,2302,730,879,86014,529,577,770-846,831,410-3,833,117,950-1,906,075,7503,006,923,200

Profile

Inscobee., Inc. engages in the smart grid, mobile virtual network operator (MVNO), bio, and distribution businesses in South Korea and internationally. It offers intelligent power network products, such as K2 chips and data concentration units, as well as PLC bridges, modems, and attenuators; and operates freeT, a mobile network operator for MVNOs of various mobile network operators. The company also provides bio medicines for pain; vaccines for cervical cancer and papillomavirus; and cosmeceuticals and nutraceuticals, as well as distributes watches. In addition, it sells smart lighting solutions, LED products, and lighting fixtures, as well as other electrical products. The company was founded in 1970 and is headquartered in Seoul, South Korea.
URL
http://www.inscobee.com
IPO date
Jan 17, 1985
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
99,811,313
30.17%
76,678,322
6.99%
71,665,525
23.95%
Cost of revenue
87,571,907
66,883,057
64,323,182
Unusual Expense (Income)
NOPBT
12,239,406
9,795,265
7,342,343
NOPBT Margin
12.26%
12.77%
10.25%
Operating Taxes
865,955
5,030
(385,016)
Tax Rate
7.08%
0.05%
NOPAT
11,373,450
9,790,234
7,727,359
Net income
(30,176,927)
307.35%
(7,408,063)
-239.66%
5,304,170
-43.00%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
16,879,989
20,972,499
24,986,826
Long-term debt
1,533,217
1,629,016
1,362,867
Deferred revenue
Other long-term liabilities
815,903
532,024
529,951
Net debt
(15,104,559)
(43,441,653)
(47,276,072)
Cash flow
Cash from operating activities
3,006,923
(1,906,076)
(3,833,118)
CAPEX
(1,620,091)
(1,013,117)
(665,837)
Cash from investing activities
(7,043,304)
(3,126,550)
(9,867,942)
Cash from financing activities
(806,430)
(2,847,253)
24,821,082
FCF
11,478,245
9,629,149
7,514,145
Balance
Cash
9,813,768
14,656,578
22,586,987
Long term investments
23,703,997
51,386,590
51,038,778
Excess cash
28,527,200
62,209,252
70,042,489
Stockholders' equity
(37,001,028)
(6,537,551)
(1,153,714)
Invested Capital
93,347,672
91,513,713
92,642,897
ROIC
12.30%
10.63%
9.47%
ROCE
21.69%
11.53%
8.03%
EV
Common stock shares outstanding
113,142
109,216
105,864
Price
1,227.00
-4.88%
1,290.00
-59.18%
3,160.00
49.76%
Market cap
138,825,581
-1.46%
140,888,188
-57.88%
334,531,182
62.11%
EV
123,654,139
97,505,852
287,291,393
EBITDA
13,816,852
11,143,608
8,474,501
EV/EBITDA
8.95
8.75
33.90
Interest
990,157
1,333,348
1,311,567
Interest/NOPBT
8.09%
13.61%
17.86%